Biotech NewsVirios Therapeutics Stock Plunges 70% on Fibromyalgia Clinical Trial Failure Results BioTech Health XSeptember 19, 2022 In a shocking failure, Virios Therapeutics announced this morning pre-market that topline results from its FORTRESS (Fibromyalgia Outcome… 0 Shares 0 0 0 0 0 0 0
Biotech NewsCEL-SCI Multikine Phase 3 Data Highlighted at ESMO 2022 BioTech Health XSeptember 10, 2022 CEL-SCI recently presented its Phase 3 data at ESMO 2022, which revealed that Neoadjuvant Multikine achieved groundbreaking tumor… 0 Shares 0 0 0 0 0 0 0